ESC 365 - Statin use after valvular heart surgery is associated with a decreased risk of prosthetic valve endocarditis

ESC Professional Premium Access

Statin use after valvular heart surgery is associated with a decreased risk of prosthetic valve endocarditis

Session: Valvular and Myocardial disease

Topic: Prevention

Speaker: Doctor Q. Ren (CN)

Event: ESC Asia 2022 with APSC & AFC

Congress Presentation

Add to my library

About the speaker

Doctor Qingwen Ren

(China)

1 follower

3 more presentations in this session

Different cellular landscape of four types of non-diseased cardiac valves contributes to their differences in susceptibility of pathological remodeling and disease

Speaker: Doctor S. Shu (Beijing, CN)

Natural history of functional mitral regurgitation: a systematic review and individual patient data meta-analysis

Speaker: Mr Y. Teo (Singapore, SG)

Association of left atrial ejection fraction and cardiovascular outcomes in Asian patients with hypertrophic cardiomyopathy

Speaker: Doctor N. Sari (Palembang, ID)

Access the full session

Valvular and Myocardial disease

Speakers: Doctor Q. Ren, Doctor S. Shu, Mr Y. Teo, Doctor N. Sari

About the event

ESC Asia 2022 with APSC & AFC

1 December - 3 December 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources